Stock screenerAll disclosures →
EDGAR →
OCUL
Conviction 50HealthcareScan · Thu, Jun 25, 2026Shooting star
OCUL$9.78-0.71%
ResistanceSupportVol 14Insider sell4
Vol MA14 3.26M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price9.78
Change-0.71%
Gap-1.07%
Rel volume1.06×
Avg volume3.02M
Avg $ vol27.73M
SMA 209.03
SMA 509.10
SMA 20010.45
Price vs 50+7.45%
Price vs 200-6.43%
MA stackmixed
50/200 cross—
Supertrendup · 8.38
RSI (14)60
MACD hist0.15
MACD cross—
Stoch %K / %D67 / 72
ADX (14)25
+DI / −DI30 / 11
RSI divergence—
MACD divergence—
ATR %+5.89%
ADR %6.27%
52w high16.11
52w low6.88
From 52w high-39.29%
Above 52w low+42.15%
New 52w highNo
SqueezeOff
Bollinger width25.79%
%B0.82
Donchian pos67.18%
Donchian high10.62
Donchian low8.07
AVWAP (52w high)9.73
vs AVWAP high+0.56%
AVWAP (52w low)8.71
vs AVWAP low+12.27%
OBV trendFlat
Chaikin MF (20)0.11
Today vs 20d1.06×
Avg vol (14d)3.26M
Avg vol (20d)3.02M
Avg $ vol (20d)27.73M
Market cap2.14B
RS 3m (vs SPY)+9.35%
RS 6m (vs SPY)-29.31%
RS line new highNo
Trend template3/8
Technical rank44.4
1 week+1.45%
1 month+17.97%
3 months+17.41%
6 months-24.54%
1 year+7.59%
YTD-17.26%
P/E-8.05
P/B3.68
P/S41.22
P/FCF-9.87
EPS-1.42
Div yield—
ROE-45.73%
ROA-36.30%
Debt/Eq0.03
Current14.81
EV/EBITDA-5.62
Gross margin—
Net margin-511.90%
Rev growth-18.47%
EPS growth-37.43%
Price target25.50
Target upside160.74%
Analyst ratingBuy
Institutional100.22%
Ent. value1.49B
Revenue10.79M
Net income-88.61M
Gross profit—
Free cash flow-216.89M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out218.96M
Employees325
ListedFri, Jul 25, 2014
Free float179.1M
Float %82.3%
Short interest25.09M
Days to cover9.0d
Short volume39.5%
Squeeze score54 / 100
Next earningsTue, Aug 4, 2026 (40d)
EPS forecast−$0.40 · 5 est
Last EPS vs est−$0.41 vs −$0.32
Last surprise-28.1% miss
Setup gradeC
Conviction50 / 100
Pattern quality—
Tech rank44.4 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmShooting star
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in OCUL
No recent disclosed trades by Congress in OCUL. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in OCUL · 3 buys · 7 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Dugel Pravin See Remarks · Common Stock · 2026-06-16 | Gift | 50.09K | — | 2026-06-16 | 2026-06-18 |
Dugel Pravin See Remarks · Common Stock · 2026-06-16 | Gift | 50.09K | — | 2026-06-16 | 2026-06-18 |
Waheed Nadia Chief Medical Officer · Common Stock · 2026-06-03 | Sell | 14.83K | $123K | 2026-06-03 | 2026-06-05 |
Dugel Pravin See Remarks · Common Stock · 2026-05-28 | Gift | 394.7K | $0 | 2026-05-28 | 2026-05-28 |
Dugel Pravin See Remarks · Common Stock · 2026-05-28 | Gift | 394.7K | $0 | 2026-05-28 | 2026-05-28 |
Dugel Pravin See Remarks · Common Stock · 2026-05-26 | Sell | 21.16K | $173K | 2026-05-26 | 2026-05-28 |
Kaiser Peter Chief Development Officer · Common Stock · 2026-05-26 | Sell | 2.97K | $24K | 2026-05-26 | 2026-05-28 |
Heier Jeffrey S. Chief Scientific Officer · Common Stock · 2026-05-26 | Sell | 3.02K | $25K | 2026-05-26 | 2026-05-28 |
Nayak Sanjay Chief Strategy Officer · Common Stock · 2026-05-26 | Sell | 1.86K | $15K | 2026-05-26 | 2026-05-28 |
Dugel Pravin See Remarks · Common Stock · 2026-04-09 | Gift | 394.7K | $0 | 2026-04-09 | 2026-04-13 |
SEC filings
EDGAR filings in OCUL · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.